Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey

Konstantinos Iliodromitis; Radoslaw Lenarczyk; Daniel Scherr; Giulio Conte; Michal M Farkowski; Francisco Marin; Javier Garcia-Seara; Stefan Simovic; Tatjana Potpara

doi:10.1093/europace/euac236

Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey

Konstantinos Iliodromitis, Radoslaw Lenarczyk, Daniel Scherr, Giulio Conte, Michal M Farkowski, Francisco Marin, Javier Garcia-Seara, Stefan Simovic, Tatjana Potpara

Clinical sciences

Research output: Contribution to journal › Article › peer-review

19 Citations (Scopus)

22 Downloads (Pure)

Abstract

Catheter ablation (CA) of atrial fibrillation (AF) is the therapy of choice for the maintenance of sinus rhythm in patients with symptomatic AF. Time towards interventional treatment and peri-procedural management of patients undergoing AF ablation may vary in daily practice. The scope of this European Heart Rhythm Association (EHRA) survey was to report the current clinical practice regarding the management of patients undergoing AF ablation and physician's adherence to the European Society of Cardiology Guidelines and the EHRA/HRS/ECAS expert consensus statement on the CA for AF. This physician-based survey was conducted among EHRA members, using an internet-based questionnaire developed by the EHRA Scientific Initiatives Committee. A total of 258 physicians participated in the survey. In patients with paroxysmal or persistent AF, 42 and 9% of the physicians would routinely perform AF ablation as first-line therapy respectively, whereas 71% of physicians would consider ablation as first-line therapy in patients with symptomatic AF and left ventricular ejection fraction <35%. Only 14% of the respondents manage cardiovascular risk factors in patients referred for CA using a dedicated AF risk factor management programme. Radiofrequency CA is the preferred technology for first-time AF (56%), followed by cryo-balloon CA (40%). This EHRA survey demonstrated a considerable variation in the management of patients undergoing AF ablation in routine practice and deviations between guideline recommendations and clinical practice.

Original language	English
Pages (from-to)	667-675
Number of pages	9
Journal	Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology
Volume	25
Issue number	2
Early online date	13 Dec 2022
DOIs	https://doi.org/10.1093/europace/euac236
Publication status	Published - 1 Feb 2023

Bibliographical note

Funding Information:
The production of this document is under the responsibility of the Scientific Initiatives Committee of the European Heart Rhythm Association: T.S.P. (Chair), R.L. (Co-Chair), G.C., Gheorghe Andrei Dan, M.M.F., Malcolm Finlay, Estelle Gandjbakhch, K.E.I., Kristine Jubele, Deirdre A. Lane, Eloi Marijon, F.M., Frits Prinzen, and D.S. The production of this document is also under the responsibility of the Scientific Initiatives Committee of the European Heart Rhythm Association: Julian K.R. Chun (Chair), Sergio Castrejon (Co-Chair), Ante Anic, G.C., Piotr Futyma, Andreas Metzner, Federico Migliore, Giacomo Mugnai, Laura Perrotta, Rui Providencia, Sergio Richter, Laurent Roten, and Arian Sultan. The authors acknowledge the EHRA Scientific Research Network centres participating in this survey. A list of these centres can be found on the EHRA website.

Publisher Copyright:
© 2022 The Author(s).

Copyright:
Copyright 2023 Elsevier B.V., All rights reserved.

Keywords

Atrial fibrillation
Catheter ablation
Clinical practice
EHRA survey
Guidelines
Physician-based survey

Access to Document

10.1093/europace/euac236Licence: CC BY-NC

93566072Final published version, 189 KBLicence: CC BY-NC

Cite this

Iliodromitis, K., Lenarczyk, R., Scherr, D., Conte, G., Farkowski, M. M., Marin, F., Garcia-Seara, J., Simovic, S., & Potpara, T. (2023). Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, 25(2), 667-675. https://doi.org/10.1093/europace/euac236

Iliodromitis, Konstantinos ; Lenarczyk, Radoslaw ; Scherr, Daniel ; Conte, Giulio ; Farkowski, Michal M ; Marin, Francisco ; Garcia-Seara, Javier ; Simovic, Stefan ; Potpara, Tatjana. / Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation : an EHRA survey. In: Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2023 ; Vol. 25, No. 2. pp. 667-675.

@article{10054fa8b68249e0992d0755f28c5df7,

title = "Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey",

abstract = "Catheter ablation (CA) of atrial fibrillation (AF) is the therapy of choice for the maintenance of sinus rhythm in patients with symptomatic AF. Time towards interventional treatment and peri-procedural management of patients undergoing AF ablation may vary in daily practice. The scope of this European Heart Rhythm Association (EHRA) survey was to report the current clinical practice regarding the management of patients undergoing AF ablation and physician's adherence to the European Society of Cardiology Guidelines and the EHRA/HRS/ECAS expert consensus statement on the CA for AF. This physician-based survey was conducted among EHRA members, using an internet-based questionnaire developed by the EHRA Scientific Initiatives Committee. A total of 258 physicians participated in the survey. In patients with paroxysmal or persistent AF, 42 and 9% of the physicians would routinely perform AF ablation as first-line therapy respectively, whereas 71% of physicians would consider ablation as first-line therapy in patients with symptomatic AF and left ventricular ejection fraction <35%. Only 14% of the respondents manage cardiovascular risk factors in patients referred for CA using a dedicated AF risk factor management programme. Radiofrequency CA is the preferred technology for first-time AF (56%), followed by cryo-balloon CA (40%). This EHRA survey demonstrated a considerable variation in the management of patients undergoing AF ablation in routine practice and deviations between guideline recommendations and clinical practice.",

keywords = "Atrial fibrillation, Catheter ablation, Clinical practice, EHRA survey, Guidelines, Physician-based survey",

author = "Konstantinos Iliodromitis and Radoslaw Lenarczyk and Daniel Scherr and Giulio Conte and Farkowski, {Michal M} and Francisco Marin and Javier Garcia-Seara and Stefan Simovic and Tatjana Potpara",

note = "Funding Information: The production of this document is under the responsibility of the Scientific Initiatives Committee of the European Heart Rhythm Association: T.S.P. (Chair), R.L. (Co-Chair), G.C., Gheorghe Andrei Dan, M.M.F., Malcolm Finlay, Estelle Gandjbakhch, K.E.I., Kristine Jubele, Deirdre A. Lane, Eloi Marijon, F.M., Frits Prinzen, and D.S. The production of this document is also under the responsibility of the Scientific Initiatives Committee of the European Heart Rhythm Association: Julian K.R. Chun (Chair), Sergio Castrejon (Co-Chair), Ante Anic, G.C., Piotr Futyma, Andreas Metzner, Federico Migliore, Giacomo Mugnai, Laura Perrotta, Rui Providencia, Sergio Richter, Laurent Roten, and Arian Sultan. The authors acknowledge the EHRA Scientific Research Network centres participating in this survey. A list of these centres can be found on the EHRA website. Publisher Copyright: {\textcopyright} 2022 The Author(s). Copyright: Copyright 2023 Elsevier B.V., All rights reserved.",

year = "2023",

month = feb,

day = "1",

doi = "10.1093/europace/euac236",

language = "English",

volume = "25",

pages = "667--675",

journal = "Europace",

issn = "1099-5129",

publisher = "Oxford University Press",

number = "2",

}

Iliodromitis, K, Lenarczyk, R, Scherr, D, Conte, G, Farkowski, MM, Marin, F, Garcia-Seara, J, Simovic, S & Potpara, T 2023, 'Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey', Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, vol. 25, no. 2, pp. 667-675. https://doi.org/10.1093/europace/euac236

Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation : an EHRA survey. / Iliodromitis, Konstantinos; Lenarczyk, Radoslaw; Scherr, Daniel; Conte, Giulio; Farkowski, Michal M; Marin, Francisco; Garcia-Seara, Javier; Simovic, Stefan; Potpara, Tatjana.

In: Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology, Vol. 25, No. 2, 01.02.2023, p. 667-675.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation

T2 - an EHRA survey

AU - Iliodromitis, Konstantinos

AU - Lenarczyk, Radoslaw

AU - Scherr, Daniel

AU - Conte, Giulio

AU - Farkowski, Michal M

AU - Marin, Francisco

AU - Garcia-Seara, Javier

AU - Simovic, Stefan

AU - Potpara, Tatjana

N1 - Funding Information: The production of this document is under the responsibility of the Scientific Initiatives Committee of the European Heart Rhythm Association: T.S.P. (Chair), R.L. (Co-Chair), G.C., Gheorghe Andrei Dan, M.M.F., Malcolm Finlay, Estelle Gandjbakhch, K.E.I., Kristine Jubele, Deirdre A. Lane, Eloi Marijon, F.M., Frits Prinzen, and D.S. The production of this document is also under the responsibility of the Scientific Initiatives Committee of the European Heart Rhythm Association: Julian K.R. Chun (Chair), Sergio Castrejon (Co-Chair), Ante Anic, G.C., Piotr Futyma, Andreas Metzner, Federico Migliore, Giacomo Mugnai, Laura Perrotta, Rui Providencia, Sergio Richter, Laurent Roten, and Arian Sultan. The authors acknowledge the EHRA Scientific Research Network centres participating in this survey. A list of these centres can be found on the EHRA website. Publisher Copyright: © 2022 The Author(s). Copyright: Copyright 2023 Elsevier B.V., All rights reserved.

PY - 2023/2/1

Y1 - 2023/2/1

N2 - Catheter ablation (CA) of atrial fibrillation (AF) is the therapy of choice for the maintenance of sinus rhythm in patients with symptomatic AF. Time towards interventional treatment and peri-procedural management of patients undergoing AF ablation may vary in daily practice. The scope of this European Heart Rhythm Association (EHRA) survey was to report the current clinical practice regarding the management of patients undergoing AF ablation and physician's adherence to the European Society of Cardiology Guidelines and the EHRA/HRS/ECAS expert consensus statement on the CA for AF. This physician-based survey was conducted among EHRA members, using an internet-based questionnaire developed by the EHRA Scientific Initiatives Committee. A total of 258 physicians participated in the survey. In patients with paroxysmal or persistent AF, 42 and 9% of the physicians would routinely perform AF ablation as first-line therapy respectively, whereas 71% of physicians would consider ablation as first-line therapy in patients with symptomatic AF and left ventricular ejection fraction <35%. Only 14% of the respondents manage cardiovascular risk factors in patients referred for CA using a dedicated AF risk factor management programme. Radiofrequency CA is the preferred technology for first-time AF (56%), followed by cryo-balloon CA (40%). This EHRA survey demonstrated a considerable variation in the management of patients undergoing AF ablation in routine practice and deviations between guideline recommendations and clinical practice.

AB - Catheter ablation (CA) of atrial fibrillation (AF) is the therapy of choice for the maintenance of sinus rhythm in patients with symptomatic AF. Time towards interventional treatment and peri-procedural management of patients undergoing AF ablation may vary in daily practice. The scope of this European Heart Rhythm Association (EHRA) survey was to report the current clinical practice regarding the management of patients undergoing AF ablation and physician's adherence to the European Society of Cardiology Guidelines and the EHRA/HRS/ECAS expert consensus statement on the CA for AF. This physician-based survey was conducted among EHRA members, using an internet-based questionnaire developed by the EHRA Scientific Initiatives Committee. A total of 258 physicians participated in the survey. In patients with paroxysmal or persistent AF, 42 and 9% of the physicians would routinely perform AF ablation as first-line therapy respectively, whereas 71% of physicians would consider ablation as first-line therapy in patients with symptomatic AF and left ventricular ejection fraction <35%. Only 14% of the respondents manage cardiovascular risk factors in patients referred for CA using a dedicated AF risk factor management programme. Radiofrequency CA is the preferred technology for first-time AF (56%), followed by cryo-balloon CA (40%). This EHRA survey demonstrated a considerable variation in the management of patients undergoing AF ablation in routine practice and deviations between guideline recommendations and clinical practice.

KW - Atrial fibrillation

KW - Catheter ablation

KW - Clinical practice

KW - EHRA survey

KW - Guidelines

KW - Physician-based survey

UR - http://www.scopus.com/inward/record.url?scp=85148307342&partnerID=8YFLogxK

U2 - 10.1093/europace/euac236

DO - 10.1093/europace/euac236

M3 - Article

C2 - 36512365

VL - 25

SP - 667

EP - 675

JO - Europace

JF - Europace

SN - 1099-5129

IS - 2

ER -

Iliodromitis K, Lenarczyk R, Scherr D, Conte G, Farkowski MM, Marin F et al. Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey. Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology. 2023 Feb 1;25(2):667-675. https://doi.org/10.1093/europace/euac236

Patient selection, peri-procedural management, and ablation techniques for catheter ablation of atrial fibrillation: an EHRA survey

Abstract

Bibliographical note

Keywords

Access to Document

Other files and links

Fingerprint

Cite this